PNC Financial Services Group
BIOA

PNC Financial Services Group’s BioAge Labs BIOA Stock Holding History

PNC Financial Services Group’s Portfolio BIOA Stock Details BIOA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$48.4K Sell
1,974
-99
-5% -$1.79K ﹤0.01% 3365
2026
Q1 		$36.3K Sell
2,073
-110
-5% -$2.12K ﹤0.01% 3401
2025
Q4 		$28.9K Sell
2,183
-11
-0.5% -$98 ﹤0.01% 3491
2025
Q3 		$12.9K Buy
2,194
+1,855
+547% +$8.69K ﹤0.01% 3830
2025
Q2 		$1.4K Buy
+339
New +$1.37K ﹤0.01% 4503

Other funds holding BIOA

ACM
AH Capital Management Menlo Park, California $14.2B AUM 20.01% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
CAM
Cormorant Asset Management Boston, Massachusetts $1.95B AUM 773.9% 1-Year Est. Return
SI
Sofinnova Investments Menlo Park, California $1.93B AUM 134.74% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
OCA
Octagon Capital Advisors New York $1.11B AUM 866.76% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
MB
MPM BioImpact Boston, Massachusetts $1.64B AUM 245.64% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PCH
Polar Capital Holdings London, United Kingdom $42.4B AUM 181.11% 1-Year Est. Return

PNC Financial Services Group's BIOA Position: Q2 2026 in Review

PNC Financial Services Group reduced its BioAge Labs (BIOA) stake by 4.8% in Q2 2026, selling an estimated $1.79K and leaving 1,974 shares worth $48.4K. The position accounts for ﹤0.01% of the portfolio, ranked #3365.

PNC Financial Services Group first reported a position in BIOA in Q2 2025 and has held it in 5 quarters since. 150 funds tracked by Wall St. Rank hold BIOA as of Q2 2026.

  • PNC Financial Services Group held 1,974 shares of BioAge Labs worth $48.4K as of Q2 2026.
  • PNC Financial Services Group sold 99 BioAge Labs shares in Q2 2026, an estimated $1.79K.
  • BioAge Labs made up ﹤0.01% of PNC Financial Services Group's portfolio in Q2 2026, its #3365 holding.
  • PNC Financial Services Group first reported a position in BioAge Labs in Q2 2025 and has held it in 5 quarters since.
  • 150 funds tracked by Wall St. Rank held BioAge Labs as of Q2 2026.

Based on PNC Financial Services Group's 13F filing for Q2 2026, filed 7 Aug 2026.